We are live on ! Find out more
THMO

ThermoGenesis Holdings, Inc. Common Stock

Delisted

THMO was delisted on the 14th of June, 2024.

14 hedge funds and large institutions have $147K invested in ThermoGenesis Holdings, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 1

30% less funds holding

Funds holding: 2014 (-6)

79% less capital invested

Capital invested by funds: $704K → $147K (-$557K)

86% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 7

Holders
14
Holders Change
-6
Holders Change %
-30%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
5
Reduced
1
Closed
7
Calls
Puts
Net Calls
Net Calls Change

THMO Hedge Fund Activity: Q2 2023 in Review

14 of the 6,383 institutional investors tracked by Wall St. Rank reported a position in ThermoGenesis Holdings, Inc. Common Stock (THMO) for Q2 2023, worth a combined $147K — down 79% from $704K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of THMO and 1 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 5 added.

The largest buyer was Raymond James & Associates, adding an estimated $43.6K. The largest seller was Armistice Capital, exiting entirely with an estimated $328K sold.

  • 14 institutional investors held ThermoGenesis Holdings, Inc. Common Stock (THMO) as of Q2 2023, down from 20 in Q1 2023.
  • Funds reported $147K of ThermoGenesis Holdings, Inc. Common Stock stock for Q2 2023, down 79% quarter-over-quarter.
  • 1 fund opened new ThermoGenesis Holdings, Inc. Common Stock positions in Q2 2023 and 7 closed out, a net change of -6 holders.
  • The largest ThermoGenesis Holdings, Inc. Common Stock buyer in Q2 2023 was Raymond James & Associates, an estimated $43.6K added.
  • The largest ThermoGenesis Holdings, Inc. Common Stock seller in Q2 2023 was Armistice Capital, an estimated $328K sold.

Based on aggregated 13F filings for Q2 2023.